Manage Your Liver
Q:

Founder of Kyotsujigyo honoured to be University Professor

Founder of Kyotsujigyo honoured to be University Professor
A:

Our founder Prof Sha has completed his Ph.D. on Health maintenance last year. And was honoured to be invited as Professor at the Musashino Gakuin University, Japan on International Communication.

 

His main focus as Professor is on Health Maintenance and disease prevention culture, Japanese Kampo, and dementia.

 

Profile

1953 - Born in Shanghai 

1981 - Graduated from Shanghai Normal University

1887 - Moved to Japan

1991 - Established Kyotsujigyo Inc.

1997 - Acquired Japanese Nationality

2015 - Complete Ph.D. on International communication   

            - Thesis: A Study on Analysis of Yojokun‐Influence from Chinese Classic Texts

2016 - Became as a Professor at the Musashino Gakuin University, Japan 

             - Health Maintenance and disease prevention.

 

Research and Patent Achievement

As a result of longstanding research based on traditional oriental medicine, he successfully formulated Yojo supplements designed to maintain and recover liver and kidney functions, anti-cancer, fatigue recovery, exercise capacity enhancement, energy enhancement, reduce medication side effects, prevent and minimise the symptoms of cold and influenza etc. 

 

Above effects have been proven through scientific researches, with these significant evidence of benefits, his products acquired 7 patents in the US, Europe, Canada, China and Japan. 

 

US        NO.6586017

     NO.6280776

     NO.7205010

Canada NO.2291974

Europe  NO.1002540

China    NO.ZL03107003.5

Japan    NO.4588132

 

Research and Academic Exchange

1999~2013    

Over 40 conferences and exchanges at Japan & oversea hepatology society and Cancer society. 

 

2002~2005

The research paper on efficacy against liver cirrhosis and NASH received two excellent awards winning at the Japan Society of Hepatology.

 

2006~2013

Published 11 times on world famous academic journals include 「Annals of New York Academy of Science.

 

2006~2013

14 pieces of research paper and results have been listing on National Medical Library (Pubmed), shared to professionals and opened to public.

 

Conferencece presentation

2013

The 16th The Japanese society for complementary and alternative medicine 

“The Search for Yo-jyo supplement possibility in hepatitis prevention and liver damage”

 

Publication

  • The amazing power of Panax and Eucommia.
  • The real health preservation of oriental medicine. 
  • Buy the finest quality herbs in Japan. 
  • No more liver cancer from Hep C.
  • Boost up your liver!
Disclaimer:
  • * All research and clinical data should be used as reference purposes only, results may vary.
Related Questions
A:
It’s almost yearend, have you achieved any health goals you wished for?  If you are still thinking about how to improve your liver health, this is your chance. We are now offering an exclusive promotion, enjoy 10% off on all orders!  Don’t miss this great chance to boost your liver health!   Special Promotion 10% OFF:  Period: 8th De
A:
Research and developing our products has always been a big part of our work. Kyotsujigyo has worked with a number of well established organisations and universities in the past, including the University of Sao Paulo, GAIA Age-Management Foundation, The University of Western Ontario, University of Virginia, Yanaihara Research Institute,  Harada Hospital (Japan) and others.    In 2016 Kyotsujigyo has corporate with the National Key Research Institute in Hong K
Hit Questions
A:
YHK has significant effect in stopping liver inflammation; it can enhance the recovery of liver health and protect liver cells. Those who have experienced YHK often have these questions in mind: Why is YHK so different from other liver medicines and supplements? Why is it possible to have such unprecedented effects? The answer seems magical, but in fact, it is not complicated - Because YHK possesses a perfect balance.   To explain this, we must first point out that YH
A:
You probably have already heard about the new antiviral hep C drug, which is effective but insanely expensive. It claims to have around 90% success rate, that’s why so many hepatitis C patients are dying for it even though it’s extremely costly. But apart from its expensive price tag, there is a bigger issue behind this new drug that not many people know about. Scientists and researchers have found an increased risk of extreme liver cancer related to this new drug after successful
A:
Hepatitis C is a wide spread and deadly disease affecting an estimated of 3.5 million Americans.   Treatment for hepatitis C has evolved over the years, going from highly toxic drugs involving injections with horrible side effects, to medications with minimal side effects. Success rate of treatment options has also improved greatly Although the high price tag of the new DAA treatment is controversial, it has undoubtedly helped to cure many hepatitis C patients.
A:
“It isn't fat but rather fibrosis that drives disease progression in people with advanced non-alcoholic steatohepatitis (NASH).”   NASH is one of the most prevalent liver diseases nowadays. NASH is related to non-alcoholic fatty liver disease (NAFLD) which is characterized by the buildup of fat in the liver. Although it is normal to have some fat in the liver, some people might develop inflammation because of this fat accumulation, this is cal
YHK Liver Therapy
Your Liver
Protection

starts here.
Buy YHK
Have Questions?
Sumbit your question to us for profeessional answers!
Looking for help? Ask our customer support team!
Contact Us